Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment

Expertise & Skills
Logo UNIBS

|

Expertise & Skills

unibs.it
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment
  1. Outputs

Imatinib mesylate in the treatment of newly diagnosed or refractory /resistant c-kit positive AML. Results of an italian multicentric phase II study.

Abstract
Publication Date:
2005
CRIS type:
4.2 Abstract in Atti di convegno
List of contributors:
Malagola, Michele; Piccaluga, Pp; Martinelli, G; Rondoni, M; Arpinati, M; Tazzari, Pl; Amabile, M; Ottaviani, E; Candoni, A; Fanin, R; Cilloni, D; Gottardi, E; Saglio, G; Bocchia, M; Lauria, F; Visani, G; Russo, Domenico; Baccarani, M.
Authors of the University:
MALAGOLA MICHELE
RUSSO DOMENICO
Handle:
https://iris.unibs.it/handle/11379/37820
Book title:
40° Congresso della Società Italiana di Ematologia
Published in:
HAEMATOLOGICA
Journal
  • Support
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.11.1.0